Skip to main content
BCRX logo

BCRX

Biocryst Pharmaceuticals Inc
$9.84 +0.19 (+1.97%) At close · Jul 2
Market Cap
$2.50B
Shares
254,162,660

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 302
Total Value: $2,280,577,852
Total Shares: 239,556,416
Showing 1–100 of 314 holdings by value · page 1 of 4

Institutional Ownership Trend

26 quarters

Holder Concentration

Across 302 13F filers
Top Holder
9.5%
Jun 2023 → Mar 2026 · range 8.8% – 13.0%
of institutional value
Top 5
32.1%
Jun 2023 → Mar 2026 · range 32.1% – 43.1%
of institutional value
Top 10
49.1%
Jun 2023 → Mar 2026 · range 45.2% – 58.9%
of institutional value
HHI
336
Jun 2023 → Mar 2026 · range 336 – 526
Broadly held
Showing 100 of 314
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 882796 CUSIP 09058V103 13F (30d) 3 filings 3 filers Visit website Investor relations